Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
9.41
+0.06 (0.60%)
At close: May 30, 2025, 4:00 PM
9.41
0.00 (0.04%)
After-hours: May 30, 2025, 4:44 PM EDT

Nuvectis Pharma Statistics

Total Valuation

Nuvectis Pharma has a market cap or net worth of $222.40 million. The enterprise value is $192.54 million.

Market Cap 222.40M
Enterprise Value 192.54M

Important Dates

The last earnings date was Tuesday, May 6, 2025, before market open.

Earnings Date May 6, 2025
Ex-Dividend Date n/a

Share Statistics

Nuvectis Pharma has 23.63 million shares outstanding. The number of shares has increased by 12.13% in one year.

Current Share Class 23.63M
Shares Outstanding 23.63M
Shares Change (YoY) +12.13%
Shares Change (QoQ) +12.27%
Owned by Insiders (%) 45.20%
Owned by Institutions (%) 9.92%
Float 12.95M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 10.61
P/TBV Ratio 10.61
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.28

Current Ratio 3.28
Quick Ratio 3.25
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -115.28% and return on invested capital (ROIC) is -75.12%.

Return on Equity (ROE) -115.28%
Return on Assets (ROA) -52.69%
Return on Invested Capital (ROIC) -75.12%
Return on Capital Employed (ROCE) -100.31%
Revenue Per Employee n/a
Profits Per Employee -$1.55M
Employee Count 13
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +46.51% in the last 52 weeks. The beta is -0.12, so Nuvectis Pharma's price volatility has been lower than the market average.

Beta (5Y) -0.12
52-Week Price Change +46.51%
50-Day Moving Average 9.42
200-Day Moving Average 7.26
Relative Strength Index (RSI) 48.71
Average Volume (20 Days) 132,054

Short Selling Information

The latest short interest is 2.10 million, so 8.90% of the outstanding shares have been sold short.

Short Interest 2.10M
Short Previous Month 1.89M
Short % of Shares Out 8.90%
Short % of Float 16.23%
Short Ratio (days to cover) 13.00

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -21.02M
Pretax Income -21.10M
Net Income -20.16M
EBITDA n/a
EBIT -21.02M
Earnings Per Share (EPS) -$1.12
Full Income Statement

Balance Sheet

The company has $29.86 million in cash and n/a in debt, giving a net cash position of $29.86 million or $1.26 per share.

Cash & Cash Equivalents 29.86M
Total Debt n/a
Net Cash 29.86M
Net Cash Per Share $1.26
Equity (Book Value) 20.95M
Book Value Per Share 0.89
Working Capital 20.95M
Full Balance Sheet

Cash Flow

Operating Cash Flow -12.06M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Nuvectis Pharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -12.13%
Shareholder Yield -12.13%
Earnings Yield -9.07%
FCF Yield n/a

Analyst Forecast

The average price target for Nuvectis Pharma is $17.00, which is 80.74% higher than the current price. The consensus rating is "Strong Buy".

Price Target $17.00
Price Target Difference 80.74%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1